Imatinib in pulmonary arterial hypertension: c-Kit inhibition (Q34782487)

4 August 2017

Imatinib in pulmonary arterial hypertension: c-Kit inhibition (English)

1 reference

4 August 2017

arterial hypertension

1 reference

1 reference

7

Fernando Torres

1 reference

4 August 2017

9

Suzy Comhair

1 reference

4 August 2017

Samar Farha

1

1 reference

4 August 2017

Raed Dweik

2

1 reference

4 August 2017

Franck Rahaghi

3

1 reference

4 August 2017

Raymond Benza

4

1 reference

4 August 2017

Paul Hassoun

5

1 reference

4 August 2017

Robert Frantz

6

1 reference

4 August 2017

Deborah A Quinn

8

1 reference

4 August 2017

Serpil Erzurum

10

1 reference

4 August 2017

Kewal Asosingh

11

1 reference

4 August 2017

1 September 2014

1 reference

4 August 2017

Pulmonary circulation

1 reference

4 August 2017

4

1 reference

4 August 2017

3

1 reference

4 August 2017

452-455

1 reference

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Potential mechanism for recruitment and migration of CD133 positive cells to areas of vascular inflammation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

Expression and function of c-kit in hemopoietic progenitor cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4278604

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

7 July 2018

1 reference

Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.

21 January 2018

1 reference

Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia

21 January 2018

1 reference

Mast cell number, phenotype, and function in human pulmonary arterial hypertension

21 January 2018

1 reference

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

21 January 2018

1 reference

Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25621158

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1086/677359

1 reference

4 August 2017

1 reference

4 August 2017

1 reference